294 related articles for article (PubMed ID: 23856744)
1. Chemotherapy dosing in overweight and obese patients with cancer.
Lyman GH; Sparreboom A
Nat Rev Clin Oncol; 2013 Aug; 10(8):451-9. PubMed ID: 23856744
[TBL] [Abstract][Full Text] [Related]
2. Appropriate chemotherapy dosing in obese patients with cancer.
Lyman GH; Sparreboom A
Nat Rev Clin Oncol; 2013 Nov; 10(11):664. PubMed ID: 24101119
[No Abstract] [Full Text] [Related]
3. Sarcopenia and chemotherapy dosing in obese patients.
Laviano A; Rianda S; Rossi Fanelli F
Nat Rev Clin Oncol; 2013 Nov; 10(11):664. PubMed ID: 24101124
[No Abstract] [Full Text] [Related]
4. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
Griggs JJ; Mangu PB; Anderson H; Balaban EP; Dignam JJ; Hryniuk WM; Morrison VA; Pini TM; Runowicz CD; Rosner GL; Shayne M; Sparreboom A; Sucheston LE; Lyman GH;
J Clin Oncol; 2012 May; 30(13):1553-61. PubMed ID: 22473167
[TBL] [Abstract][Full Text] [Related]
5. Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
Raman R; Mott SL; Schroeder MC; Phadke S; El Masri J; Thomas A
Clin Breast Cancer; 2016 Dec; 16(6):480-486. PubMed ID: 27431461
[TBL] [Abstract][Full Text] [Related]
6. Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.
Miyahara T; Mochinaga S; Kimura S; Aragane N; Yakabe T; Morita S; Okudaira K; Fujito H
Cancer Chemother Pharmacol; 2013 Jan; 71(1):175-82. PubMed ID: 23064956
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice.
Greenman CG; Jagielski CH; Griggs JJ
Cancer; 2008 May; 112(10):2159-65. PubMed ID: 18338813
[TBL] [Abstract][Full Text] [Related]
8. Are medical oncologists biased in their treatment of the large woman with breast cancer?
Madarnas Y; Sawka CA; Franssen E; Bjarnason GA
Breast Cancer Res Treat; 2001 Mar; 66(2):123-33. PubMed ID: 11437098
[TBL] [Abstract][Full Text] [Related]
9. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
Stocker G; Hacker UT; Fiteni F; John Mahachie J; Roth AD; Van Cutsem E; Peeters M; Lordick F; Mauer M
Eur J Cancer; 2018 Aug; 99():49-57. PubMed ID: 29906734
[TBL] [Abstract][Full Text] [Related]
10. Obesity and chemotherapy administration: between empiric and mathematic method review.
Bouleftour W; Mery B; Chanal E; Rowinski E; Viard A; Forges F; Fournel P; Rivoirard R
Acta Oncol; 2019 Jun; 58(6):880-887. PubMed ID: 30907190
[No Abstract] [Full Text] [Related]
11. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
[TBL] [Abstract][Full Text] [Related]
12. Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.
Lote H; Sharp A; Redana S; Papadimitraki E; Capelan M; Ring A
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):597-603. PubMed ID: 26936608
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy and Anticancer Drugs Adjustment in Obesity: A Narrative Review.
Thimotheo Batista JP; Santos Marzano LA; Menezes Silva RA; de Sá Rodrigues KE; Simões E Silva AC
Curr Med Chem; 2023; 30(9):1003-1028. PubMed ID: 35946096
[TBL] [Abstract][Full Text] [Related]
14. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).
Au-Yeung G; Webb PM; DeFazio A; Fereday S; Bressel M; Mileshkin L
Gynecol Oncol; 2014 Apr; 133(1):16-22. PubMed ID: 24680586
[TBL] [Abstract][Full Text] [Related]
15. Dosing considerations for obese patients receiving cancer chemotherapeutic agents.
Hall RG; Jean GW; Sigler M; Shah S
Ann Pharmacother; 2013 Dec; 47(12):1666-74. PubMed ID: 24259627
[TBL] [Abstract][Full Text] [Related]
16. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update.
Griggs JJ; Bohlke K; Balaban EP; Dignam JJ; Hall ET; Harvey RD; Hecht DP; Klute KA; Morrison VA; Pini TM; Rosner GL; Runowicz CD; Shayne M; Sparreboom A; Turner S; Zarwan C; Lyman GH
J Clin Oncol; 2021 Jun; 39(18):2037-2048. PubMed ID: 33939491
[TBL] [Abstract][Full Text] [Related]
17. [A case of acute myeloid leukemia in an obese patient--determining the therapeutic dose of anticancer drugs].
Kawaguchi Y; Inagaki A; Sato Y; Ogura H; Wakita A
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2603-5. PubMed ID: 25596056
[TBL] [Abstract][Full Text] [Related]
18. Inconsistencies in dosage practice in children with overweight or obesity: A retrospective cohort study.
Gade C; Christensen HR; Dalhoff KP; Holm JC; Holst H
Pharmacol Res Perspect; 2018 Jun; 6(3):e00398. PubMed ID: 29721323
[TBL] [Abstract][Full Text] [Related]
19. Myelosuppression by chemotherapy in obese patients with gynecological cancers.
Kamimura K; Matsumoto Y; Zhou Q; Moriyama M; Saijo Y
Cancer Chemother Pharmacol; 2016 Sep; 78(3):633-41. PubMed ID: 27485538
[TBL] [Abstract][Full Text] [Related]
20. Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).
Hunter RJ; Navo MA; Thaker PH; Bodurka DC; Wolf JK; Smith JA
Cancer Treat Rev; 2009 Feb; 35(1):69-78. PubMed ID: 18922643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
